Morabito, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 345
AS - Asia 310
EU - Europa 196
SA - Sud America 88
AF - Africa 9
Totale 948
Nazione #
US - Stati Uniti d'America 333
SG - Singapore 149
BR - Brasile 72
SE - Svezia 57
CN - Cina 51
IT - Italia 34
IN - India 31
FR - Francia 29
VN - Vietnam 28
DE - Germania 23
IE - Irlanda 19
AR - Argentina 11
ID - Indonesia 10
GB - Regno Unito 9
JP - Giappone 7
KR - Corea 6
RU - Federazione Russa 6
AT - Austria 4
MA - Marocco 4
PL - Polonia 4
ZA - Sudafrica 4
BD - Bangladesh 3
CA - Canada 3
HK - Hong Kong 3
MX - Messico 3
SA - Arabia Saudita 3
BO - Bolivia 2
IQ - Iraq 2
NL - Olanda 2
NP - Nepal 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
FI - Finlandia 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 948
Città #
Singapore 86
Chandler 53
Ashburn 41
San Jose 38
New York 25
Hyderabad 19
Dallas 18
Dublin 13
Hefei 11
Ho Chi Minh City 11
Lauterbourg 11
Beijing 9
Florence 9
Frankfurt am Main 9
Jakarta 9
Hanoi 8
Los Angeles 8
Düsseldorf 7
Tokyo 7
Marseille 6
Milan 6
Princeton 6
San Mateo 6
Seoul 6
São Paulo 6
Belo Horizonte 5
Nuremberg 5
Wilmington 5
Brooklyn 4
Genoa 4
Pune 4
Vicopisano 4
Boston 3
Buenos Aires 3
Falls Church 3
Haiphong 3
Hong Kong 3
Norwalk 3
Queens 3
The Dalles 3
Wroclaw 3
Araraquara 2
Campinas 2
Cattolica 2
Chicago 2
Córdoba 2
Fairfield 2
Fremont 2
Garden City 2
Goiânia 2
Houston 2
Jeddah 2
Johannesburg 2
Kent 2
London 2
Maracaibo 2
Moscow 2
Pelotas 2
Portsmouth 2
Rio de Janeiro 2
Salvador 2
Santa Clara 2
Tashkent 2
Toronto 2
Turin 2
Verona 2
Washington 2
Addis Ababa 1
Agua Prieta 1
Alegre 1
Alvorada 1
Andover 1
Aparecida de Goiânia 1
Arapiraca 1
Arcoverde 1
Arroio do Tigre 1
Ashgabat 1
Athens 1
Atlanta 1
Baghdad 1
Banda Aceh 1
Barrinha 1
Bengaluru 1
Blumenau 1
Boqueirão do Leão 1
Bratislava 1
Brockton 1
Brussels 1
Can Tho 1
Cape Town 1
Caracal 1
Carapicuíba 1
Caseros 1
Catanduva 1
Caucaia 1
Chaguanas 1
Chandīgarh 1
Charleston 1
City of London 1
Claypole 1
Totale 571
Nome #
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 154
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 122
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 114
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 109
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 102
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study 97
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 93
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia 87
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study 81
Totale 959
Categoria #
all - tutte 4.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 21 18 15 2 0 10 4 1 17 5
2022/2023124 17 17 4 15 7 19 6 7 21 0 8 3
2023/2024105 6 16 8 10 7 39 0 6 0 3 4 6
2024/2025222 5 5 11 10 13 9 10 8 27 51 43 30
2025/2026415 76 19 33 41 70 28 65 24 32 27 0 0
Totale 959